FDA Class II · Drug · May 13, 2026
NAPROXEN ORAL SUSPENSION recall — Acella Pharmaceuticals, LLC
Chemical contamination; presence of lead and lithium above specification
Official ID D-0523-2026 · Official record ↗
Acella Pharmaceuticals recalls
Recall found. Acella Pharmaceuticals is named in FDA Class II recall D-0523-2026 covering NAPROXEN ORAL SUSPENSION. Hazard: Chemical contamination; presence of lead and lithium above specification Identifying details: Lot: 23F02, Expires: 05/2026; 25A37, Expires: 01/2028.. Status: Ongoing.
Models with recalls
All Acella Pharmaceuticals recalls
Verify with the official sources:
- CPSC — consumer products ↗ (aggregated here)
- NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
- FDA — food, drugs, medical devices ↗ (aggregated here)
- USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
- Recalls.gov — the U.S. government’s all-agency portal ↗
Found something wrong or missing? Report a data error.
Compiled from official public-domain government data. Last checked October 22, 2026 at 6:00 PM UTC.